English: Thank you for the questions. I'm not able to give you a hard percentage estimate of the impact of the adverse weather, but we are aware there was a significant amount of activity that was pulled, and rather than plucking figures out of the air, what I am committing to doing is to making sure that we continue to provide daily information, that we continue to provide twice-weekly information on a Tuesday and a Thursday giving more detail, so people will be able to see transparently the progress we're making on each of these priority groups, on the backdrop of the assurance of the much greater pace that we have demonstrated we can deliver when the supply is with us. I note that you asked about when we'll catch up with England on the over-80s. Actually, on some of the other categories of health and social care workers, we are, of course, ahead of England, but I'm only being asked about areas where we're behind England. All that information will be continue to be provided about where we are, and you'll see that again in the information that is being published on a daily basis by Public Health Wales. So, I think we have a good approach to being transparent with our data and our information, and in the level of assurance people can have that that published data is accurate. We are accelerating in our use of the Pfizer vaccine. As I have said repeatedly, we are providing as much as our NHS can deliver. We know that we have new ways where we can be a bit more flexible in the use of Pfizer now as well, and that's a good thing too. So, we haven't just built up our infrastructure; we've got additional ways of using that as well. When it comes to commercial sensitivity, I think I dealt with this earlier in response to Rhun ap Iorwerth, and also in the opening as well. It's about making sure that we're as transparent as we possibly can be, but taking account of the sensitivities that exist around stock numbers. When it comes to the second dose of vaccines, we are of course already planning for those, and we're having to consider then what that means in terms of the use of our stock, especially for the Pfizer vaccine, because the first groups of people who will be eligible for their second dose will be people who have had the Pfizer vaccine itself. So, we need to make sure we have stocks of those to deliver second vaccines whilst still being able to carry on the work of getting through the first not just four priority groups, but the first nine priority groups we have, with the vaccines available. That is partly why added supplies of the AstraZeneca vaccine are so important to us.
Welsh: Diolch am y cwestiynau. Ni allaf i roi amcangyfrif canrannol pendant i chi o effaith y tywydd mawr, ond rydym ni'n ymwybodol bod cryn dipyn o weithgarwch wedi cael ei dynnu'n ôl, ac yn hytrach na thynnu ffigurau o'r awyr, yr hyn yr wyf i'n ymrwymo i'w wneud yw sicrhau ein bod ni'n parhau i gyflwyno gwybodaeth yn ddyddiol, ein bod ni'n parhau i gyflwyno gwybodaeth ddwywaith yr wythnos ar ddydd Mawrth a dydd Iau sy'n rhoi rhagor o fanylion, fel y bydd pobl yn gallu gweld yn dryloyw y cynnydd a wnawn ni yn ôl pob un o'r grwpiau blaenoriaeth hyn, yng nghyd-destun sicrwydd y cyflymder uwch yr ydym ni wedi dangos y gallwn ei gyflawni pan fydd y cyflenwad ar gael i ni. Rwy'n nodi eich bod wedi gofyn pryd y byddwn ni'n dal i fyny â Lloegr o ran pobl dros 80 oed. Mewn gwirionedd, o ran rhai o'r categorïau eraill o weithwyr iechyd a gofal cymdeithasol, rydym ni, wrth gwrs, ar y blaen i Loegr, ond dim ond am y meysydd yr ydym ni y tu ôl i Loegr yr wyf i'n cael fy holi. Fe fydd yr holl wybodaeth honno am ein sefyllfa ni'n parhau i gael ei chyflwyno, ac fe welwch chi hynny eto yn yr wybodaeth a gaiff ei chyhoeddi'n ddyddiol gan Iechyd Cyhoeddus Cymru. Felly, rwyf i o'r farn fod gennym ddull da o fod yn dryloyw gyda'n data ni a'n gwybodaeth ni, ac yn lefel y sicrwydd y gall pobl ei gael bod y data a gyhoeddir hynny'n gywir. Mae ein defnydd ni o frechlyn Pfizer yn cyflymu. Fel yr wyf i wedi ei ddweud dro ar ôl tro, rydym ni'n gweinyddu cymaint ag y gall ein GIG ei gyflenwi. Fe wyddom fod gennym ddulliau newydd lle mae modd bod ychydig yn fwy hyblyg nawr wrth ddefnyddio brechlyn Pfizer, ac mae hynny'n beth da hefyd. Felly, nid adeiladu ar ein seilwaith yn unig a wnawn ni; mae gennym ffyrdd ychwanegol o ddefnyddio hwnnw hefyd. O ran sensitifrwydd masnachol, rwy'n credu imi ymdrin â hyn yn gynharach wrth roi ateb i Rhun ap Iorwerth, ac wrth agor hefyd. Mae'n ymwneud â sicrhau ein bod ni mor dryloyw ag y gallwn fod, ond gan gofio'r sensitifrwydd sy'n bodoli o ran niferoedd y stoc. O ran ail ddos y brechlynnau, rydym ni eisoes, wrth gwrs, yn cynllunio ar gyfer y rhain, ac fe fydd yn rhaid inni ystyried bryd hynny beth mae hynny'n ei olygu o ran defnyddio ein stoc ni, yn enwedig o ran brechlyn Pfizer, oherwydd y grwpiau cyntaf o bobl a fydd yn gymwys i gael eu hail ddos fydd y bobl sydd wedi cael y brechlyn Pfizer ei hun. Felly, mae angen inni sicrhau bod gennym stociau o hwnnw i roi'r ail frechiadau wrth barhau â'r gwaith o fynd trwy nid yn unig y pedwar grŵp blaenoriaeth cyntaf, ond y naw grŵp blaenoriaeth cyntaf sydd gennym ni, gyda'r brechlynnau sydd ar gael. Dyna pam, yn rhannol, mae cyflenwadau ychwanegol o frechlyn AstraZeneca mor bwysig i ni.